A new study shows that some cases of early-onset Alzheimer disease result from duplications of the APP locus, which encodes the amyloid β precursor protein. This finding fulfills a 20-year-old prediction that genetic variability in APP expression could lead to disease and provides further, perhaps definitive, evidence for the amyloid hypothesis of the disorder.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
Scientific Reports Open Access 24 April 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Glenner, G.G. & Wong, C.W. Biochem. Biophys. Res. Commun. 120, 885–890 (1984).
Glenner, G.G. & Wong, C.W. Biochem. Biophys. Res. Commun. 122, 1131–1135 (1984).
Rovelet-Lecrux, A. et al. Nat. Genet. 38, 24–26 (2006).
Goate, A. et al. Nature 349, 704–706 (1991).
Levy, E. et al. Science 248, 1124–1126 (1990).
Hardy, J. & Selkoe, D.J. Science 297, 353–356 (2002).
Hendriks, L. et al. Nat. Genet. 1, 218–221 (1992).
Remes, A.M. et al. Neurology 63, 234–240 (2004).
Prasher, V.P. et al. Ann. Neurol. 43, 380–383 (1998).
Wavrant-De Vrièze, F. et al. Neurosci. Lett. 269, 67–70 (1999).
Singleton, A.B. et al. Science 302, 841 (2003).
Lupski, J.R. et al. Cell 66, 219–232 (1991).
Kumar-Singh, S. et al. Am. J. Pathol. 167, 527–543 (2005).
Tuzun, E. et al. Nat. Genet. 37, 727–732 (2005).
Singleton, A., Myers, A. & Hardy, J. Hum. Mol. Genet. 13, R123–R126 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hardy, J. Amyloid double trouble. Nat Genet 38, 11–12 (2006). https://doi.org/10.1038/ng0106-11
Issue Date:
DOI: https://doi.org/10.1038/ng0106-11
This article is cited by
-
Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
Scientific Reports (2020)
-
Mitochondria at the neuronal presynapse in health and disease
Nature Reviews Neuroscience (2018)
-
Catalytic Immunoglobulin Gene Delivery in a Mouse Model of Alzheimer’s Disease: Prophylactic and Therapeutic Applications
Molecular Neurobiology (2015)
-
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)
The Pharmacogenomics Journal (2007)
-
Amyloid at the blood vessel wall
Nature Medicine (2006)